Treatment - Group 3—Monomethylhydrazine (Gyromitrin)

How to Subscribe
MLS & MLT Comprehensive CE Package
Includes 183 CE courses, most popular
$109Add to cart
Pick Your Courses
Up to 8 CE hours
$55Add to cart
Individual course$25Add to cart
The page below is a sample from the LabCE course Mushroom Poisoning and the Laboratory's Role in Monitoring Patients. Access the complete course and earn ASCLS P.A.C.E.-approved continuing education credits by subscribing online.

Learn more about Mushroom Poisoning and the Laboratory's Role in Monitoring Patients (online CE course)
Treatment - Group 3—Monomethylhydrazine (Gyromitrin)

Fortunately, Group 3 poisonings account for only 1% of all mushroom poisonings in the United States. The percentages are higher in European countries. Benzodiazepines or pyridoxine may be administered IV to overcome seizures. Since hydrazine inhibits the transformation of folic acid, patients with severe Group 3 toxicity should be given folic acid as an adjunctive therapy. Patients should be closely monitored for further complications such as potential destruction of skeletal muscle, methemoglobinemia, and hemolysis.